Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 5741517, 5 pages
http://dx.doi.org/10.1155/2016/5741517
Research Article

Circadian Rhythms of Oxidative Stress Markers and Melatonin Metabolite in Patients with Xeroderma Pigmentosum Group A

1Department of Brain Development and Neural Regeneration, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan
2Department of Pediatrics, Tokyo-Kita Medical Center, Tokyo 171-0053, Japan
3Department of Pediatrics, Tokyo Metropolitan Fuchu Medical Center for the Disabled, Tokyo 183-8553, Japan

Received 17 February 2016; Accepted 10 April 2016

Academic Editor: Grégory Durand

Copyright © 2016 Rie Miyata et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. H. Kraemer, N. J. Patronas, R. Schiffmann, B. P. Brooks, D. Tamura, and J. J. DiGiovanna, “Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship,” Neuroscience, vol. 145, no. 4, pp. 1388–1396, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Nishigori, S.-I. Moriwaki, H. Takebe, T. Tanaka, and S. Imamura, “Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan,” Archives of Dermatology, vol. 130, no. 2, pp. 191–197, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Hayashi, “Oxidative stress in developmental brain disorders,” Neuropathology, vol. 29, no. 1, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Halliwell, “Oxidative stress and neurodegeneration: where are we now?” Journal of Neurochemistry, vol. 97, no. 6, pp. 1634–1658, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Ozaki, N. Sanjo, K. Ishikawa et al., “Elevation of 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of three patients with superficial siderosis,” Neurology and Clinical Neuroscience, vol. 3, no. 3, pp. 108–110, 2015. View at Publisher · View at Google Scholar
  6. R. Miyata, M. Hayashi, N. Tanuma, K. Shioda, R. Fukatsu, and S. Mizutani, “Oxidative stress in neurodegeneration in dentatorubral-pallidoluysian atrophy,” Journal of the Neurological Sciences, vol. 264, no. 1-2, pp. 133–139, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Hayashi, S. Araki, J. Kohyama, K. Shioda, and R. Fukatsu, “Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome,” Brain and Development, vol. 27, no. 1, pp. 34–38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Hayashi, K. R. Miyata, and N. Tanuma, “Oxidative stress in developmental brain disorders,” in Neurodegenerative Diseases, S. I. Ahmad, Ed., pp. 278–299, Springer, New York, NY, USA, 2012. View at Google Scholar
  9. S. R. Pandi-Perumal, A. S. Bahammam, G. M. Brown et al., “Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes,” Neurotoxicity Research, vol. 23, no. 3, pp. 267–300, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. B. M. Escribano, A. L. Colín-González, A. Santamaría, and I. Túnez, “The role of melatonin in multiple sclerosis, huntington's disease and cerebral ischemia,” CNS and Neurological Disorders—Drug Targets, vol. 13, no. 6, pp. 1096–1119, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Claustrat and J. Leston, “Melatonin: physiological effects in humans,” Neurochirurgie, vol. 61, no. 2-3, pp. 77–84, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Okoshi, N. Tanuma, R. Miyata, and M. Hayashi, “Melatonin alterations and brain acetylcholine lesions in sleep disorders in Cockayne syndrome,” Brain and Development, vol. 36, no. 10, pp. 907–913, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Wilking, M. Ndiaye, H. Mukhtar, and N. Ahmad, “Circadian rhythm connections to oxidative stress: implications for human health,” Antioxidants and Redox Signaling, vol. 19, no. 2, pp. 192–208, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Hayashi, K. Nakajima, R. Miyata, and N. Tanuma, “The combined pathological, physiological and pharmacological examinations are useful to evaluate the hypothalamic and circadian rhythm disturbances in developmental brain disorders,” in Neuropathology New Research, A. Estevo and T. Honrado, Eds., pp. 113–124, Nova Science, New York, NY, USA, 2012. View at Google Scholar
  15. R. Miyata, T. Sasaki, M. Hayashi, S. Araki, M. Shimohira, and J. Kohyama, “Low-dose levodopa is effective for laryngeal dystonia in xeroderma pigmentosum group A,” Brain and Development, vol. 32, no. 8, pp. 685–687, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Muto, A. Matsui, Y. Saito et al., “Laryngeal dystonia in xeroderma pigmentosum,” Brain and Development, vol. 27, no. 8, pp. 598–601, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Ohto, N. Iwasaki, H. Okubo, K. Shin, and A. Matsui, “Life-threatening vocal cord paralysis in a patient with group A xeroderma pigmentosum,” Pediatric Neurology, vol. 30, no. 3, pp. 222–224, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. I. S. Grew, V. Cejvanovic, K. Broedbaek et al., “Diurnal variation of urinary markers of nucleic acid oxidation,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 74, no. 4, pp. 336–343, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Faraut, V. Bayon, and D. Léger, “Neuroendocrine, immune and oxidative stress in shift workers,” Sleep Medicine Reviews, vol. 17, no. 6, pp. 433–444, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Sancar, L. A. Lindsey-Boltz, T.-H. Kang, J. T. Reardon, J. H. Lee, and N. Ozturk, “Circadian clock control of the cellular response to DNA damage,” FEBS Letters, vol. 584, no. 12, pp. 2618–2625, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Gringras, C. Gamble, A. P. Jones et al., “Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial,” British Medical Journal, vol. 345, Article ID e6664, 2012. View at Google Scholar
  22. B. Wright, D. Sims, S. Smart et al., “Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial,” Journal of Autism and Developmental Disorders, vol. 41, no. 2, pp. 175–184, 2011. View at Publisher · View at Google Scholar · View at Scopus